Bolt Biotherapeutics, Inc. · NASDAQ:BOLT
Quinn William P. bought 637 and sold 17,566 Bolt Biotherapeutics, Inc. shares (Form 4)
Traded Jun 5 to Sep 18, 2026 · Filed Sep 21, 2026
From Jun 5 to Sep 18, 2026, Quinn William P. (Director, President, CEO and CFO) bought 637 and sold 17,566 Bolt Biotherapeutics, Inc. shares, leaving 25,384 shares. Filed Sep 21, 2026 (Form 4).
- Bought
- 637 shares (US$2,472 at US$3.88)
- Sold
- 17,566 shares (US$58,439 at an average US$3.33)
- Holding after
- 25,384 shares
- Trading plan
- No
- Role
- Director, President, CEO and CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Buy | 637 | US$3.88 | 2,950 | Direct |
| Sep 16, 2026 | Common Stock | Sale | 1,889 | US$3.77 | 41,061 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 6,545 | US$3.32 | 34,516 | Direct |
| Sep 18, 2026 | Common Stock | Sale | 9,132 | US$3.24 | 25,384 | Direct |
Source
Related
- Bolt Biotherapeutics, Inc.
- Quinn William P.
- Bolt Biotherapeutics, Inc. shareholders
- Form 4 · Yonehiro Grant · Sep 21, 2026
- Form 4 · Nemec Sarah · Sep 21, 2026
- Schedule 13G · Renaissance Technologies LLC · Aug 13, 2026
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 26, 2026
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 17, 2026